Severe morbidity as an important concept in the fight for women
octubre 29, 20162 lectura mínima
Though we focus on maternal mortality and maternal death, in many settings, 'near misses' are equally important as both a public health concept and a human rights issue. The 'near miss' in obstetrics refers to a woman who was critically ill and would have died had it not been for care. Severe acute maternal morbidity (SAMM) in low-income countries.
Put another way, in looking at the health system, it is important to identify what factors led to death, and what factors helped narrowly avert death. In assessing the efficacy of a safe motherhood system, policymakers must look at the prevalence of near misses-- a decrease in the number of maternal deaths accompanied by an increase in severe acute maternal morbidity is of concern.
The rate of severe acute maternal mortality was found to be [.80% – 8.23% in studies that use disease-specific criteria while the range is 0.38% – 1.09% in the group that use organ-system based criteria and included unselected group of women] (http://www.reproductive-health-journal.com/content/1/1/3)
In a recent paper, Ronsmans and team studies a range of SAMM studies and noted that "is clearly illustrated in the studies that more SAMM cases are likely to die in resource-poor settings than in more developed country settings. For example, the studies conducted in Niger, Benin and Malaysia give the morbidity to mortality ratio as 11–12 [10,15,17] while this is 117–223 in studies conducted in Europe [11,18] in the category where disease-specific criteria are used. The same applies to the category of organ-system based criteria; morbidity: mortality ratio is 5–8 in South Africa [1,14,15] and 49 in Scotland . These findings suggest that an indicator that relates SAMM to maternal deaths could be a useful method in assessing the care SAMM cases receive."
Jean M. Bouquet, DO, is an Assistant Professor of Family Medicine and Co-Director of the Urban Underserved Track at the Rocky Vista University College of Osteopathic Medicine. He is the founder of the Bouquet Speculum, an innovative and FDA-cleared medical device that helps to screen women for cervical cancer. Dr. Bouquet also started the Cure Cervical Cancer nonprofit. The following blog post was written by Dr. Bouquet about his journey to creating the Bouquet Speculum.
Dr. Daniel Kimani is a trained and licensed medical officer in Kenya, holding a Bachelor of Medicine & Surgery, and a post-graduate certificate on basic oncology training. Dr. Kimani is the founder of the Global Cancer Care and Research Institute, and is an expert in clinical colposcopy — a procedure to examine the cervix, vagina, and vulva.